Pharmaceutical Printer of Inserts, Labels and More

Since 1928, we have been at the forefront of development in the pharmaceutical print industry. Beyond our reputation as the preeminent pharmaceutical printer, we now supply labeling and printing services for medical devices, as well as the bio-tech industry. We are committed to developing and then printing innovative materials that make it easier for you to get vital information to your customers. We do it all through a tried and tested foundation in Current Good Manufacturing Practices (CGMP) and ISO 9001:2015 standards that constantly work to achieve consistency in all of our print processes.

We are proud to boast that Pharmaceutic Litho is one of the few pharmaceutical printers with over 75,000 sq. ft. dedicated solely to pharmaceutical printing. Even so, we continue to grow and expand our secondary packaging services for the pharmaceutical and bio-tech industries in order to build on our reputation as the standard for quality and service in the pharma printing industries.

LATEST NEWS: Pharmaceutic Litho & Label Company Acquires Plymouth Printing

Wilton, CT — Pharmaceutic Litho & Label Company is excited to announce the acquisition of Plymouth Printing Company, Inc. As a current Good Manufacturing Practices (cGMP) compliant specialty printer that exclusively serves the pharmaceutical, biotech and medical device industries... continue reading

Pharmaceutical Printer Products

Inserts & Outserts

Pharmaceutical Inserts Outserts

Pharmaceutical Printing
Labels

Pharma Labels

Pharmaceutical Printing
Booklets

Pharmaceutical Booklets

Pharmaceutical Printing
Manuals

Pharmaceutical Manuals

Pharmaceutical Printing

years in print

loyal clients

annual orders

printed items each year

Pharmaceutical Printer News

Mylan Launches Generic Version Of The Novartis Exelon Patch

Mylan N.V. today announced the U.S. launch of Rivastigmine Transdermal System, 4.6 mg/24 hrs, 9.5 mg/24 hrs and 13.3 mg/24 hrs, a generic version of Novartis’ Exelon Patch. Mylan received final approval fromRead More…

Posted in Company News, Healthcare, Label Printing, Labels, Pharmaceutical Label, Pharmaceutical Printer, Pharmaceutical Printing, Pharmaceuticals | Tagged , , , , , , , , , , , | Leave a comment

FDA Approves Genentech’s Rituxan For Pemphigus Vulgaris

The U.S. Food and Drug Administration (FDA) has approved Genentech’s Rituxan (rituximab) for the treatment of adults with moderate to severe pemphigus vulgaris (PV), a rare, serious, potentially life-threatening condition characterized by progressive painfulRead More…

Posted in Label Printing, Labels, Pharma Labels, Pharma Printing, Pharmaceutical Label, Pharmaceutical Label Printer, Pharmaceutical Print, Pharmaceutical Printing, Pharmaceuticals | Tagged , , , , , , , , , | Leave a comment

FDA Grants Priority Review of Genentech’s Tecentriq

Genentech, a member of the Roche Group today announced that the FDA has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq (atezolizumab), in combination with Avastin (bevacizumab), paclitaxelRead More…

Posted in Biopharmaceutical, Pharma, Pharma Labels, Pharma Printing, Pharmaceutical Label, Pharmaceuticals | Tagged , , , , , , , | Leave a comment

Missed What You Were Looking For? Below Are The Most Popular Inquiries